ZA939673B - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
ZA939673B
ZA939673B ZA939673A ZA939673A ZA939673B ZA 939673 B ZA939673 B ZA 939673B ZA 939673 A ZA939673 A ZA 939673A ZA 939673 A ZA939673 A ZA 939673A ZA 939673 B ZA939673 B ZA 939673B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparation
atovaquone
production
relates
improved bioavailability
Prior art date
Application number
ZA939673A
Other languages
English (en)
Inventor
Alan Roy Dearn
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA939673B publication Critical patent/ZA939673B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fertilizers (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA939673A 1992-12-24 1993-12-23 Pharmaceutical preparation ZA939673B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226905A GB9226905D0 (en) 1992-12-24 1992-12-24 Pharmaceutical preparation

Publications (1)

Publication Number Publication Date
ZA939673B true ZA939673B (en) 1995-06-23

Family

ID=10727175

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939673A ZA939673B (en) 1992-12-24 1993-12-23 Pharmaceutical preparation

Country Status (36)

Country Link
US (2) US6018080A (fr)
EP (1) EP0675711B1 (fr)
JP (1) JP3461353B2 (fr)
KR (1) KR0175193B1 (fr)
CN (1) CN1076194C (fr)
AT (1) ATE169215T1 (fr)
AU (2) AU675102B2 (fr)
BG (1) BG61932B1 (fr)
BR (1) BR9307719A (fr)
CA (1) CA2152615C (fr)
CZ (1) CZ289701B6 (fr)
DE (1) DE69320208T2 (fr)
DK (1) DK0675711T3 (fr)
ES (1) ES2122223T3 (fr)
FI (1) FI114007B (fr)
GB (1) GB9226905D0 (fr)
GE (1) GEP19991515B (fr)
HK (1) HK1004086A1 (fr)
HR (1) HRP931516B1 (fr)
HU (1) HU220215B (fr)
IL (1) IL108154A (fr)
MY (1) MY109990A (fr)
NO (1) NO316745B1 (fr)
NZ (1) NZ258995A (fr)
PL (1) PL175374B1 (fr)
RO (1) RO119686B1 (fr)
RU (1) RU2127585C1 (fr)
SA (1) SA94140644B1 (fr)
SG (1) SG43901A1 (fr)
SI (1) SI9300678A (fr)
SK (1) SK281924B6 (fr)
TW (2) TW514531B (fr)
UA (1) UA39879C2 (fr)
WO (1) WO1994014426A1 (fr)
YU (1) YU48919B (fr)
ZA (1) ZA939673B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
AU3705695A (en) * 1994-10-26 1996-05-23 Wellcome Foundation Limited, The Pharmaceutical composition comprising atovaquone
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
JP2002504505A (ja) * 1998-02-25 2002-02-12 アボット・ラボラトリーズ ブトルファノール持続放出性製剤
US6503949B1 (en) 1999-05-17 2003-01-07 Noro Nordisk A/S Glucagon antagonists/inverse agonists
US6562807B2 (en) 2000-06-23 2003-05-13 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6821960B2 (en) 2000-11-17 2004-11-23 Noyo Nordisk Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
AU2002223500A1 (en) 2000-11-17 2002-05-27 Novo-Nordisk A/S Glucagon antagonists/inverse agonists
US6706744B2 (en) 2000-11-17 2004-03-16 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6881746B2 (en) 2001-12-03 2005-04-19 Novo Nordick A/S Glucagon antagonists/inverse agonists
US6762318B2 (en) 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
US7183518B2 (en) * 2004-09-24 2007-02-27 Michael Near System of food storage preparation and delivery in finished cooked state
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
WO2006108637A2 (fr) * 2005-04-13 2006-10-19 Abbott Gmbh & Co.Kg Procede de production soigneuse de suspensions de particules tres fines, particules tres fines correspondantes et leur utilisation
US20080241254A1 (en) * 2007-01-02 2008-10-02 Suryakant Navale Pharmaceutical composition comprising atovaquone particles
DE102007001473A1 (de) 2007-01-08 2008-07-10 Andreas Lemke Verfahren zur Herstellung und Anwendung von Mikro- und/oder Nanosuspensionen durch aufbauende Mikronisierung in Gegenwart von Trockeneis und hohem Druck
WO2009007991A2 (fr) * 2007-04-19 2009-01-15 Ipca Laboratories Limited Nouveau procédé de préparation d'atovaquone et ses nouveaux intermédiaires
US20110206770A1 (en) * 2008-07-25 2011-08-25 Alphapharm Pty. Ltd. Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns
US20100099776A1 (en) * 2008-10-20 2010-04-22 Ranbaxy Laboratories Limited Oily suspension of atovaquone
US8987234B2 (en) 2009-08-20 2015-03-24 Ipca Laboratories Ltd. Complex for treatment and/or prophylaxis of parasitic infections
ES2727733T3 (es) 2009-11-10 2019-10-18 Celgene Corp Nanosuspensión de un fármaco poco soluble preparada por el proceso de microfluidización
WO2011151418A2 (fr) 2010-06-02 2011-12-08 Abbott Gmbh & Co. Kg Formulation de nanosuspension comprenant une phase hydrophobe de polydiméthylsiloxane
CA2895529C (fr) 2012-12-19 2018-08-21 Kashiv Pharma, Llc Nanoparticules stabilisees super saturees pour des medicaments mediocrement solubles
WO2015071841A1 (fr) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes de dabigatran et ses dérivés, procédé de préparation de ceux-ci et compositions pharmaceutiques contenant ceux-ci
US20190321310A1 (en) * 2016-06-16 2019-10-24 The University Of Liverpool Chemical composition
US20220265566A1 (en) * 2018-10-18 2022-08-25 Tulex Pharmaceuticals Inc. Atovaquone nanoparticulate compositions

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (fr) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
IL56013A (en) * 1977-11-22 1983-06-15 Wellcome Found 2-cycloalkyl-3-hydroxy-1,4-naphthoquinone derivatives,their preparation and therapeutic compositions containing them
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485117A (en) 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
DE3141691A1 (de) * 1981-10-21 1983-05-19 Hoechst Ag, 6230 Frankfurt Plasmid pac 1, verfahren zu seiner gewinnung und seine verwendung
US5175319A (en) 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL85097A (en) * 1987-01-30 1992-02-16 Exxon Chemical Patents Inc Catalysts based on derivatives of a bis(cyclopentadienyl)group ivb metal compound,their preparation and their use in polymerization processes
PL276385A1 (en) * 1987-01-30 1989-07-24 Exxon Chemical Patents Inc Method for polymerization of olefines,diolefins and acetylene unsaturated compounds
US4783389A (en) * 1987-03-27 1988-11-08 E. I. Du Pont De Nemours And Company Process for preparation of liquid electrostatic developers
US5155080A (en) * 1988-07-15 1992-10-13 Fina Technology, Inc. Process and catalyst for producing syndiotactic polyolefins
US5225500A (en) * 1988-07-15 1993-07-06 Fina Technology, Inc. Process and catalyst for producing syndiotactic polyolefins
SG23618G (en) * 1988-08-16 1995-09-18 Wellcome Found Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
KR930002411B1 (ko) * 1988-09-14 1993-03-30 미쓰이세끼유 가가꾸고오교오 가부시끼가이샤 벤젠불용성 유기알루미늄 옥시화합물 및 그 제조방법
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
ATE137770T1 (de) * 1989-10-10 1996-05-15 Fina Technology Metallocenkatalysator mit lewissäure und alkylaluminium
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
DE69026679T3 (de) * 1989-10-30 2005-10-06 Fina Technology, Inc., Houston Addition von Alkylaluminium zum Verbessern eines Metallocenkatalysators
US5387568A (en) * 1989-10-30 1995-02-07 Fina Technology, Inc. Preparation of metallocene catalysts for polymerization of olefins
DE3942363A1 (de) * 1989-12-21 1991-06-27 Hoechst Ag Verfahren zur herstellung einer polypropylen-formmasse
JP2545006B2 (ja) * 1990-07-03 1996-10-16 ザ ダウ ケミカル カンパニー 付加重合触媒
JP3076619B2 (ja) 1991-05-14 2000-08-14 三井化学株式会社 ブロック共重合体の製造方法
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
US5766522A (en) * 1996-07-19 1998-06-16 Morton International, Inc. Continuous processing of powder coating compositions
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
US5914135A (en) * 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions

Also Published As

Publication number Publication date
BG99723A (bg) 1996-01-31
NO316745B1 (no) 2004-04-26
UA39879C2 (uk) 2001-07-16
TW514531B (en) 2002-12-21
SK281924B6 (sk) 2001-09-11
HRP931516A2 (en) 1995-10-31
AU696662B2 (en) 1998-09-17
FI114007B (fi) 2004-07-30
RU2127585C1 (ru) 1999-03-20
JPH08504805A (ja) 1996-05-28
SG43901A1 (en) 1997-11-14
PL309629A1 (en) 1995-10-30
US6018080A (en) 2000-01-25
SA94140644B1 (ar) 2005-06-14
US6649659B1 (en) 2003-11-18
CZ145195A3 (en) 1995-10-18
NO952522D0 (no) 1995-06-22
NO952522L (no) 1995-06-22
SK82895A3 (en) 1995-11-08
DE69320208T2 (de) 1999-01-21
CN1103290A (zh) 1995-06-07
HRP931516B1 (en) 1999-04-30
GEP19991515B (en) 1999-03-05
FI953139A (fi) 1995-06-22
ES2122223T3 (es) 1998-12-16
TW443935B (en) 2001-07-01
CA2152615A1 (fr) 1994-07-07
AU1627997A (en) 1997-05-22
DK0675711T3 (da) 1999-05-03
DE69320208D1 (de) 1998-09-10
IL108154A0 (en) 1994-04-12
FI953139A0 (fi) 1995-06-22
YU48919B (sh) 2002-11-15
PL175374B1 (pl) 1998-12-31
ATE169215T1 (de) 1998-08-15
YU80893A (sh) 1997-03-07
HK1004086A1 (en) 1998-11-13
HU220215B (hu) 2001-11-28
HU9501812D0 (en) 1995-08-28
KR0175193B1 (ko) 1999-02-01
HUT71528A (en) 1995-12-28
SI9300678A (en) 1994-09-30
RO119686B1 (ro) 2005-02-28
CN1076194C (zh) 2001-12-19
IL108154A (en) 2000-02-17
BR9307719A (pt) 1999-08-31
GB9226905D0 (en) 1993-02-17
BG61932B1 (bg) 1998-10-30
AU675102B2 (en) 1997-01-23
JP3461353B2 (ja) 2003-10-27
KR950703942A (ko) 1995-11-17
CZ289701B6 (cs) 2002-03-13
MY109990A (en) 1997-10-31
AU5710594A (en) 1994-07-19
CA2152615C (fr) 2001-10-16
EP0675711B1 (fr) 1998-08-05
EP0675711A1 (fr) 1995-10-11
NZ258995A (en) 1997-01-29
WO1994014426A1 (fr) 1994-07-07

Similar Documents

Publication Publication Date Title
ZA939673B (en) Pharmaceutical preparation
AU587308B2 (en) Process for the production of synthesis gas
GR3015634T3 (en) Process for the preparation of micronised biodegradable particles.
HU9102385D0 (en) Process for the production of medical preparations
HU902047D0 (en) Process for the preparation of pharmaceutical product
HU903003D0 (en) Process for the production of a medicative preparation
HU890492D0 (en) Process for the production of pharmaceutical preparations for curing dyslipaemia
HU911198D0 (en) Process for the production of a medical preparation
HUT65256A (en) Process for producing 2-mercapto methylene-tetrahydronaphtalene-2-carboxamide derivatives and pharmaceutical preparations containing them
HUT37430A (en) Process for the production of pteridin-derivatives of pharmaceutical effect
AU1514092A (en) Improved process for the production of phosphated guar
HUT35694A (en) Process for producing 2'-deoxy-oxanosine and pharmaceutical compositions containing them
HU9200294D0 (en) Process for the production of medical preparations
HU902255D0 (en) Process for the production of anti-parasitic products
EP0596286A3 (fr) Procédé pour la préparation de 5-amino-3-méthylpyrazol.
EP0498452A3 (en) Process for the production of protease c
HU9201176D0 (en) Process for the production of a diurethic medical preparation
SG55164A1 (en) Process for the production of d--g(a)-amino acid
HU9201652D0 (en) Process for the production of a medical preparation of high clarity
HU903473D0 (en) Process for the production of beta-cyclodextrine based inclusion as a medical product
HU902532D0 (en) Process for the preparation of a medicative product
GB9320795D0 (en) Process the production of pharmaceutical formulations
AU626381C (en) A process for the production and purification of succinic acid
HU913995D0 (en) Process for the production of medical preparation
HU908350D0 (en) Process for the production of medicaments